Titel

Merkliste
1 Ergebnisse

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolu..:

Wolchok, JD ; Chiarion-Sileni, V ; Gonzalez, R...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 40 (2), pp. 127 - 137. , 2022

Link: https://repository.icr.ac.uk/handle/internal/5061

RT Journal
T1 <Title>Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftinstcancerres:oai:repository.icr.ac.uk:internal_5061&Exemplar=1&LAN=DE
				
A1 Wolchok, JD
A1 Chiarion-Sileni, V
A1 Gonzalez, R
A1 Grob, J-J
A1 Rutkowski, P
A1 Lao, CD
A1 Cowey, CL
A1 Schadendorf, D
A1 Wagstaff, J
A1 Dummer, R
A1 Ferrucci, PF
A1 Smylie, M
A1 Butler, MO
A1 Hill, A
A1 Márquez-Rodas, I
A1 Haanen, JBAG
A1 Guidoboni, M
A1 Maio, M
A1 Schöffski, P
A1 Carlino, MS
A1 Lebbé, C
A1 McArthur, G
A1 Ascierto, PA
A1 Daniels, GA
A1 Long, GV
A1 Bas, T
A1 Ritchings, C
A1 Larkin, J
A1 Hodi, FS
YR 2022
K1 Humans
K1 Melanoma
K1 Skin Neoplasms
K1 Disease Progression
K1 Antineoplastic Combined Chemotherapy Protocols
K1 Neoplasm Staging
K1 Time Factors
K1 Ipilimumab
K1 Nivolumab
K1 Progression-Free Survival
JF Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 40 (2), pp. 127 - 137
LK http://dx.doi.org/https://repository.icr.ac.uk/handle/internal/5061
DO https://repository.icr.ac.uk/handle/internal/5061
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)